Apollon Financial’s Iterum Therapeutics ITRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$249K Hold
250,250
0.05% 192
2025
Q1
$308K Hold
250,250
0.07% 169
2024
Q4
$443K Buy
250,250
+25,500
+11% +$45.1K 0.11% 124
2024
Q3
$245K Hold
224,750
0.07% 150
2024
Q2
$257K Hold
224,750
0.08% 126
2024
Q1
$346K Buy
224,750
+24,750
+12% +$38.1K 0.12% 110
2023
Q4
$394K Buy
+200,000
New +$394K 0.16% 96